Table 5.
Variables | Vaccine acceptance | Vaccine hesitancy | Vaccine non-acceptance | p |
---|---|---|---|---|
Mistrust of vaccine benefit | .000** | |||
Low | 24(2.4%) | 76(7.5%) | 105(10.4%) | |
Intermediate | 160(15.8%) | 425(24.0%) | 97(9.6%) | |
High | 7(.7%) | 42(4.2%) | 75(7.4%) | |
Worries about unforeseen effects | .000** | |||
Low | 35(3.5%) | 32(3.2%) | 13(1.3%) | |
Intermediate | 122(12.1%) | 211(20.9%) | 74(7.3%) | |
High | 102(10.1%) | 300(29.7%) | 122(12.1%) | |
Concerns about commercial profiteering | .000** | |||
Low | 83(8.2%) | 76(7.5%) | 30(3.0%) | |
Intermediate | 144(14.2%) | 343(33.9%) | 120(11.9%) | |
High | 32(3.2%) | 124(12.3%) | 59(5.8%) | |
Preference of natural immunity over vaccination | .000** | |||
Low | 56(5.5%) | 74(7.3%) | 24(2.4%) | |
Intermediate | 167(16.5%) | 341(33.7%) | 125(12.4%) | |
High | 36(3.6%) | 128(12.7%) | 60(5.9%) |
*Significant at the .05 level (2-tailed).
**Significant at the .01 level (2-tailed).